Jupiter Orphan Therapeutics Inc (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies.In September 2021, Jupiter Neurosciences, Inc announced that the Company headquarters has moved to a new location, 1001 North US HWY 1, Suite #504, Jupiter, FL 33477.In January 2017, the company secured $2 million financing commitment which was in the form of a convertible note with the first $1 million paid out immediately and the remaining $1 million to be paid when certain milestones were met. In addition, the company received $500,000 in an equity financing through a charity based financing group